Cabergoline : a new drug for the treatment of hyperprolactinaemiaFERRARI, C; PISCITELLI, G; CROSIGNANI, P. G et al.Human reproduction (Oxford. Print). 1995, Vol 10, Num 7, pp 1647-1652, issn 0268-1161Article

Fast separation of dihydro ergot alkaloids on an octylsilica columnPAPP, E.Journal of chromatography. 1990, Vol 502, Num 1, pp 241-242, issn 0021-9673, 2 p.Article

Identification and quantification of ergotamine in human plasma by gas chromatography-mass spectrometryNINGPING FENG; MINDER, E. I; GRAMPP, T et al.Journal of chromatography. Biomedical applications. 1992, Vol 575, Num 2, pp 289-294, issn 0378-4347Article

Mutagenicity studies on dihydroergocristineDUBINI, F; BIGNAMI, P; ZANOTTI, A et al.Drugs under experimental and clinical research. 1990, Vol 16, Num 6, pp 255-261, issn 0378-6501, 7 p.Article

Chronische Dihydroergotamin-Intoxikation mit schweren, multifokalen zerebralen IschämienODENTHAL, H. J; RAWERT, B; JOSEPHS, W et al.Intensivmedizin + Notfallmedizin. 1990, Vol 27, Num 5, pp 260-263, issn 0175-3851Article

Amelioration of ergotamine with drawal symptoms with naproxenMATHEW, N. T.Headache. 1987, Vol 27, Num 3, pp 130-133, issn 0017-8748Article

Structure activity relationship and therapeutica uses of dopaminergic ergotsMARKSTEIN, R; SEILER, M. P; JATON, A et al.Neurochemistry international. 1992, Vol 20, Num MAR, pp 211S-214S, issn 0197-0186, SUPConference Paper

Immunosuppressive effect of ergot-alkaloid dihydroergosine in vitroSMEJKAL-JAGAR, L; BORANIC, M; PERICIC, D et al.Medical science research. 1991, Vol 19, Num 18, pp 597-598, issn 0269-8951Article

L'ergotisme, hier et aujourd'hui. Deuxième partie : l'ergotisme aujourd'hui = Ergotism, past and presentEUCHER, P; LALOUX, P; SCHOEVAERDTS, J. C et al.Louvain médical. 1996, Vol 115, Num 5, pp 315-323, issn 0024-6956Article

Zum Vorkommen von Mykotoxinen in Getreide = On the occurence of mycotoxins in cerealsWOLFF, J.Getreide, Mehl und Brot (1972). 1995, Vol 49, Num 3, pp 139-147, issn 0367-4177Article

Teratogen update : ergot and ergotamineRAYMOND, G. V.Teratology (Philadelphia, PA). 1995, Vol 51, Num 5, pp 344-347, issn 0040-3709Article

The study of the differential pulse voltammetric behaviour of ergot alkaloids and their determination by DC amperometric detection in a FIA systemINCZEFFY, J; SOMODI, Z. B; PAP-SZIKLAY, Z et al.Journal of pharmaceutical and biomedical analysis. 1993, Vol 11, Num 3, pp 191-196, issn 0731-7085Conference Paper

Intérêt de l'hydergine dans le traitement des surdités brusques = Hydergine in the treatment of Sudden hearing lossMORGON, A.Journal français d'oto-rhino-laryngologie (1977). 1987, Vol 36, Num 2, pp 65-69, issn 0398-9771Article

Dihydroergotamine therapy in orthostatic hypotension due to psychotropic drugsTHULESIUS, O; BERLIN, E.International journal of clinical pharmacology, therapy and toxicology (1980). 1986, Vol 24, Num 9, pp 465-467, issn 0174-4879Article

Lesson of the month (1): Cabergoline ― 'I eat funny on that'VIDATH SASANKA PREMARATNE; SAEGER, Ivan; MACDONALD, Bridget K et al.Clinical medicine. 2014, Vol 14, Num 2, pp 205-207, issn 1470-2118, 3 p.Article

The treatment with cabergoline for 24 months normalizes the quality of seminal fluid in hyperprolactinaemic malesDE ROSA, Michele; CICCARELLI, Antonio; ZARRILLI, Stefano et al.Clinical endocrinology (Oxford. Print). 2006, Vol 64, Num 3, pp 307-313, issn 0300-0664, 7 p.Article

Ergot induced myocardial ischaemia in a patient without vasospastic disorderPAZ, I; CARMELI, Y.Journal of the Royal Society of Medicine. 1994, Vol 87, Num 1, pp 44-45, issn 0141-0768Article

Dhydroergocryptine in the management of senile psycho-organic syndromeSCARZELLA, L; BONO, G; BERGAMASCO, B et al.International journal of clinical pharmacology research. 1992, Vol 12, Num 1, pp 37-46, issn 0251-1649Article

Pharmacokinetic investigation of oral and IV dihydroergotamine in healthy subjectsWYSS, P. A; ROSENTHALER, J; NÜESCH, E et al.European journal of clinical pharmacology. 1991, Vol 41, Num 6, pp 597-602, issn 0031-6970Article

Ergotamine dependency, a reviewSAPER, J. R.Headache. 1987, Vol 27, Num 8, pp 435-438, issn 0017-8748Article

Effect of dihydroergotamine on +G₂ acceleration toleranceJENNINGS, T. J; SEAWORTH, J. F; HOWELL, L. L et al.Cardiovascular research. 1986, Vol 20, Num 5, pp 389-392, issn 0008-6363Article

Subacute toxicity of α-ergocryptine in Sprague-Dawley rats. 1: general toxicological effectsJANSSEN, G. B; BEEMS, R. B; SPEIJERS, G. J. A et al.Food and chemical toxicology. 2000, Vol 38, Num 8, pp 679-688, issn 0278-6915Article

8α-Hydroxy-α-ergokryptine, an ergot alkaloidCVAK, L; JEGOROV, A; PAKHOMOVA, S et al.Phytochemistry. 1997, Vol 44, Num 2, pp 365-369, issn 0031-9422Article

Pharmakokinetik von Dihydroergocristin nach intravenöser und oraler Applikation bei Ratten = Pharmacokinetics of dihydroergocristine following intravenous and oral administration in ratsGROGNET, J. M; RIVIERE, R; ISTIN, M et al.Arzneimittel-Forschung. 1992, Vol 42, Num 11A, pp 1394-1396, issn 0004-4172Article

A case of portal thrombosis arisen after treatment with dihydroergotamineIAQUINTO, G; AMBROSONE, L; ROTIROTI, D et al.The Italian journal of gastroenterology. 1991, Vol 23, Num 4, pp 219-221, issn 0392-0623, 3 p.Article